• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Medical Equipment

GLIAQ:US

0.0001 USD 0.00000.00%

As of 20:10:00 ET on 03/26/2014.

Snapshot for Gliatech Inc (GLIAQ)

Open: - Day's Range: - Volume: 300
Previous Close: 0.0001 52wk Range: 0.0001 - 0.0001 1-Yr Rtn: -

Stock Chart for GLIAQ

No chart data available.
  • GLIAQ:US 0.0001
  • 1D
  • 1M
  • 1Y
0.0001
Interactive GLIAQ Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GLIAQ

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -2.2400
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 9.68
30 Day Average Volume 10
Price/Book (mrq) -
Price/Sale (ttm) 0.0003
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GLIAQ

No data available

Company Profile & Key Executives for GLIAQ

Gliatech, Inc. researches, develops, and commercializes its family of resorbable, carbohydrate polymer medical devices. The Company's products are designed to inhibit surgical scarring and adhesions, and also pursues the development of small molecule drug candidates for the treatment of several central nervous system disorders. Gliatech serves patients in the United States.

John J MalloyInterim VP:Quality SystemsThomas F BarnishVP/CFO
Leslie S SchnollDir:Quality Assurance
More Company Profile & Key Executives for GLIAQ

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil